The first edition of the Category C medical insurance catalog is coming this year! What types of medicines will be included? Learn in advance

The National Medical Insurance Administration held a press conference yesterday (17th) to introduce that in 2024, the medical insurance fund will operate smoothly and safely, and more high-quality and affordable pharmaceutical consumables will enter people's "medicine boxes." This year, centralized purchasing of new batches of drugs and high-value medical consumables will be launched soon; in addition, the first version of the Class C medical insurance catalog will be released.

What are Class C drugs? What drugs may be included in the Class C medical insurance list? How to further improve the level of medical security?

Category C drugs refer to non-clinically necessary, higher-priced drugs, which usually include health products, imported drugs, new special drugs, etc. At present, the Category C drug catalog has not yet been formally formed. However, the National Medical Insurance Administration stated that it will take a variety of measures to actively guide and support people-benefiting commercial health insurance, include the Category C drug list in the coverage, and will launch the first version of the Category C drug catalog this year. What is the specific operating situation of the basic medical insurance fund in 2024? How to improve the level of medical security in the future?

Data from the National Medical Insurance Administration shows that the total revenue of the national basic medical insurance fund will reach 3.48 trillion yuan and the total expenditure will be 2.97 trillion yuan in 2024. The excessive growth of expenditure has been curbed. The current balance of the National Medical Insurance Co-ordination Fund is 0.47 trillion yuan, and the cumulative balance is 3.87 trillion yuan. The annual medical insurance outpatient settlement reached 6.7 billion, a year-on-year increase of 19%. Jiang Chengjia, director of the Department of Regulation, Finance and Law of the National Medical Insurance Administration, said that while ensuring the safe and sustainable operation of the medical insurance fund, new progress has been made in coordinating the mutual aid role of the fund and ensuring reproductive medical care.

Jiang Chengjia, Director of the Department of Regulation, Finance and Law of the National Medical Insurance Administration: Among all fund expenditures, the proportion of overall fund expenditures will increase by 2 percentage points in 2023, reaching 80.3%, indicating that the fund's mutual assistance efficiency has been further enhanced. Since 2018, the total revenue of the National Basic Medical Insurance Fund has been 19.70 trillion yuan, and the total expenditure has been 16.48 trillion yuan, of which the overall fund revenue has been 15.19 trillion yuan, and the expenditure has been 12.78 trillion yuan, with average annual growth rates of around 11%. The fundamentals of safe and stable fund operation are certain.

To ensure that the long-term operation of medical insurance funds is safe and sustainable, the problem that needs to be solved is "how to spend the money." This money cannot be taken away by fraud. Last year, the National Medical Insurance Administration used a big data supervision model to accurately supervise issues such as "abnormal hospitalizations" and "trafficking of medical insurance drugs". Gu Rong, director of the Fund Supervision Department of the National Medical Insurance Administration, revealed that this year will increase the punishment of fraud and insurance fraud; comprehensively promote the supervision and application of drug traceability codes, and accurately crack down on reselling "reflux drugs" and exchanging medical insurance drugs.